Page last updated: 2024-10-30

mebendazole and Bile Duct Cancer

mebendazole has been researched along with Bile Duct Cancer in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Mebendazole (MBZ) is an anthelmintic drug which inhibits tubulin polymerization and eventually causes apoptosis in target organisms."5.40EFFECT OF THE ANTIPARASITIC DRUG MEBENDAZOLE ON CHOLANGIOCARCINOMA GROWTH. ( Riggins, GJ; Sawanyawisuth, K; Williamson, T; Wongkham, S, 2014)
"Mebendazole (MBZ) is an anthelmintic drug which inhibits tubulin polymerization and eventually causes apoptosis in target organisms."1.40EFFECT OF THE ANTIPARASITIC DRUG MEBENDAZOLE ON CHOLANGIOCARCINOMA GROWTH. ( Riggins, GJ; Sawanyawisuth, K; Williamson, T; Wongkham, S, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sawanyawisuth, K1
Williamson, T1
Wongkham, S1
Riggins, GJ1

Other Studies

1 other study available for mebendazole and Bile Duct Cancer

ArticleYear
EFFECT OF THE ANTIPARASITIC DRUG MEBENDAZOLE ON CHOLANGIOCARCINOMA GROWTH.
    The Southeast Asian journal of tropical medicine and public health, 2014, Volume: 45, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line,

2014